Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 10-13 September 2024

Philipp Lambach; Sheetal Silal; Alyssa N Sbarra; Mitsuki Koh; Rakesh Aggarwal; Habib Hasan Farooqui; Stefan Flasche; Alexandra B Hogan; Sun-Young Kim; Kathy Leung; William J Moss; Patrick K Munywoki; Allison Portnoy; Meru Sheel; Xuan-Yi Wang

doi:10.1016/j.vaccine.2024.126519

Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 10-13 September 2024

Vaccine. 2025 Jan 1;43(Pt 2):126519. doi: 10.1016/j.vaccine.2024.126519. Epub 2024 Nov 12.

Authors

Affiliations

¹ Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
² Modelling and Simulation Hub, Africa, University of Cape Town, Cape Town, South Africa; Centre for Global Health, Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
³ Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. Electronic address: [email protected].
⁴ Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India.
⁵ College of Medicine, QU Health, Qatar University, Qatar.
⁶ Centre for Global Health, Charite, Berlin, Germany.
⁷ School of Population Health, University of New South Wales, Sydney, Australia.
⁸ Seoul National University, Seoul, South Korea.
⁹ School of Public Health, The University of Hong Kong, Hong Kong, SAR, China.
¹⁰ Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
¹¹ Kenya Medical Research Institute, Centre for Global Health Research, Nairobi, Kenya.
¹² Department of Global Health, Boston University School of Public Health, Boston, United States; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, United States.
¹³ School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Sydney Infectious Diseases Institute, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
¹⁴ Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.

PMID: 39536476
DOI: 10.1016/j.vaccine.2024.126519

Abstract

The Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) is the primary advisory body of the World Health Organization conducting independent reviews of immunization-related implementation research, with a primary focus on transmission and economic modeling analyses that estimate the value and impact of vaccines. From 10 to 13th September 2024, IVIR-AC convened virtually for its second of two semi-annual meetings to provide feedback and recommendations across six sessions including: pneumococcal vaccination strategies that rely on indirect protection; vaccine impact modeling for chikungunya; The Lancet Commission on strengthening the use of epidemiological modeling of emerging and pandemic infectious diseases; methods for immunization coverage estimation; setting immunization research priorities in the South-East Asian Region; and modeling evidence related to typhoid conjugate vaccine schedules. This report summarizes the sessions, proceedings, and recommendations from that meeting.

Keywords: IVIR-AC; Immunization; Vaccine; WHO.

MeSH terms

Advisory Committees*
Chikungunya Fever / prevention & control
Global Health
Humans
Immunization / methods
Immunization Programs
Immunization Schedule
Vaccination / methods
Vaccines / administration & dosage
World Health Organization*

Substances

Vaccines

Grants and funding

001/WHO_/World Health Organization/International